AlloVir, Inc.

NASDAQ:ALVR

9.65 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 00008.380000000000000000000.165
Cost of Revenue 00000.1413.64300.5471.0940.1990.4260.8460.5540.0440.0330.01800000000
Gross Profit 00008.239-3.6430-0.547-1.094-0.199-0.426-0.846-0.554-0.044-0.033-0.01800000000.165
Gross Profit Ratio 00000.9830000000000000000001
Reseach & Development Expenses 0.32-0.2460.09312.17333.23134.15631.3130.71828.4230.00431.37929.06741.60333.06225.67720.39316.75717.1828.8856.8396.6875.6552.7551.151
General & Administrative Expenses 19.2045.8837.16910.66210.46412.80515.99412.51312.01412.94613.24514.12614.19312.44211.97810.478.6596.7183.2683.0012.8182.8233.191.787
Selling & Marketing Expenses 000000000000000000000000
SG&A 19.2045.8837.16910.66210.46412.80515.99412.51312.01412.94613.24514.12614.19312.44211.97810.478.6596.7183.2683.0012.8182.8233.191.787
Other Expenses 0.1260.08300.7541.2121.1670.5210.7230.9850.21-0.027-0.818-1.22-0.259-0.408-0.565-0.3780.1740.3550.0440.0970.4270.140.133
Operating Expenses 19.655.727.26222.83543.69546.96147.30443.23140.43442.9544.62443.19355.79645.50437.65530.86325.41623.912.1539.849.5058.4785.9452.938
Operating Income -19.65-5.72-7.262-22.835-43.836-46.961-47.304-43.231-40.434-42.95-44.624-43.193-55.796-45.504-37.655-30.863-25.416-23.9-12.153-9.84-9.505-8.478-5.945-2.773
Operating Income Ratio 0000-5.231000000000000000000-16.806
Total Other Income Expenses Net 1.3821.5941.186-7.464-15.9862.6892.0372.0481.8830.8780.135-0.67-1.138-0.0060.067-0.060.2170.2860.5210.5010.7621.2080.6430.249
Income Before Tax -18.268-4.126-6.076-30.299-59.822-44.272-45.267-41.183-38.551-42.072-44.489-43.863-56.934-45.51-37.588-30.923-25.199-23.614-11.632-9.339-8.743-7.27-5.302-2.524
Income Before Tax Ratio 0000-7.139000000000000000000-15.297
Income Tax Expense 000-0.1-0.126-0.086-1.516-2.048-0.415-0.8780.150.671.007-0.253-0.475-0.505-0.613-0.13-0.185-0.457-0.665-9.259-6.448-1.903
Net Income -18.268-4.126-6.076-30.299-59.696-44.272-45.267-39.135-38.136-41.194-44.639-44.533-57.941-45.51-37.588-30.923-25.199-23.614-11.632-9.339-8.743-7.27-5.302-2.524
Net Income Ratio 0000-7.124000000000000000000-15.297
EPS 0-0.036-0.053-0.26-0.52-0.39-0.48-0.42-0.41-0.48-0.69-0.7-0.92-0.72-0.6-0.5-0.41-0.58-0.19-0.22-0.21-0.17-0.13-0.06
EPS Diluted 0-0.036-0.053-0.26-0.52-0.39-0.48-0.42-0.41-0.48-0.69-0.7-0.92-0.72-0.6-0.5-0.41-0.58-0.19-0.22-0.21-0.17-0.13-0.06
EBITDA -19.524-5.637-7.774-22.736-43.695-46.961-47.219-43.231-40.348-42.865-44.538-42.727-55.702-45.46-37.622-30.845-25.398-23.882-12.134-9.822-9.51.2080.6430.249
EBITDA Ratio 0000-5.214000000000000000000-16.806